TREATMENTS
The majority of bladder cancers arise from the lining of the bladder. Over 75 percent of these tumors remain confined to the linin layer and do not invade into the bladder wall. These tummors are called superficial transitional cell cancers. Advanced bladder cancer is cancer which has invaded into the bladder wall or outside the bladder. Advanced cancer treatment options are different than those for superficial bladder cancer.
Bladder cancer treatment is determined due to the stage and grade of the tumor(s).
TREATMENT FOR SUPERFICIAL BLADDER CANCER CAN INCLUDE:
- Cystoscopy with cautery destruction of the tumor
- Most modern cystoscopes are equipped with channels that permit small instruments to be passed into the bladder for the purpose of removing tissue, stopping bleeding with a special electrical device called an electrocautery or even performing laser treatment. If the bladder cancer tumor is small enough this cautery may be used to remove cancer.
- TUR(Trans-Urethral Resection)
- This is when the tumor is removed via electrical force from the urinary tract through the urethra. TUR is an endoscopic or scope procedure that does not involve making an incision in the body. The entire removal of the bladder tumor can be accomplished through an operative scope which is passed through the urethra into the bladder.
- Drug therapy after TUR is commonly prescribed for patients with tumors that are large, multiple or high grade.
- Intravesical drug therapy /Immunotherapy
- Here medicines are placed directly into the bladder (intravesical) via a urethral catheter in order to lower the recurrence rate of bladder tumors. This is usually used for multiple CIS large in size (5 cm plus), high grade in stage tumors. About 50-68% of patients with superficial bladder cancer have a very good response to intravesical therapy.
- Commonly used intravesical drugs are:
- Mitomycin C which kills the normal DNA function in cancer cells and is easily absorbed into the bloodstream through the bladder's lining
- Bacille Calmette-Guerin (BCG) forces the immune system to respond to the BCG drug in the lining of the bladder, thus forcing the body's immune system to help fight off the cancer